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A lymphoepithelioma-like carcinoma (LLC), characterized by a carcinoma with stromal heavy lymphocyte infiltration,
is one of the histological patterns observed in patients with Epstein-Barr virus (EBV)-associated gastric carcinoma.
Although this entity is hard to be recognized in the biopsy specimens, pathologists and clinicians should acknowledge
this subset of gastric cancer because it generally has a better prognosis than other forms of EBV-associated gastric
carcinomas and conventional gastric carcinomas. This might be due to the fact that the patient's inflammatory
response may prevent the spread of tumor through the gastric wall and to the lymph nodes or remote organs.
We report a case of EBV-positive, microsatellite stable LLC as a rare morphologic variant of gastric carcinoma.
Virtual slides: The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1360498724104351.
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Lymphoepithelioma-like carcinoma (LLC) of the stomach
is a rare and peculiar type of gastric carcinoma that
was first described by Watanabe et al in 1976 as gastric
carcinoma with a lymphoid stroma [1,2]. It constitutes
about 4% of all gastric carcinomas [3,4]. Two subsets of
gastric cancer, Epstein-Barr virus (EBV)-positive and
microsatellite instability (MSI)-high cancers, have been
associated with a lymphocyte-rich phenotype [5]. More
than 80% of lymphoepithelioma-like gastric carcinomas
have been found to be associated with EBV infection
and express only several EBV-latent genes (Latency I
program) [6] as opposed to 6% and 7% of diffuse and
intestinal-type adenocarcinomas respectively [7]. The
prevalence of MSI-high in gastric carcinomas ranges
from 7% to 39% with geographic variability [5].
In this report, we highlight this rare variant of gastric
cancer and discuss its association with EBV and the role
of mismatch repair proteins in gastric LLC.
Case presentation
This is a 68-year-old gentleman with past medical history
of hypertension, hypothyroidism, depression, and panic* Correspondence: zeid.bittar@med.uni-tuebingen.de
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reproduction in any medium, provided the orattacks, presented with epigastric pain. No nausea, vomiting,
hematemesis, or weight loss reported. He underwent
endoscopic biopsy that showed a poorly differentiated
adenocarcinoma. He was referred to a tertiary center
for further evaluation. His physical examination was
unremarkable. Laboratories were normal. Upper endoscopy
revealed an ulcerated polypoid tumor involving the
greater curvature. The endoscopic ultrasound (EUS)
showed thickening of the gastric wall with destruction
of the layered structure without infiltration or penetration
of the serosa.
The repeated biopsy revealed a carcinoma with solid
proliferation and associated moderate chronic gastritis
without evidence of Helicobacter pylori. The histological
type of the tumor could not be identified (Figure 1).
The dense stromal lymphocyte infiltrate thought to be
superimposed probably secondary to the ulceration.
The computed tomography (CT) was negative for ascites,
lymph nodes enlargement, peritoneal carcinomatosis,
or liver metastases. On the basis of these findings, and
considering the patient’s age and general condition a
gastrectomy was performed with lymph nodes dissection
and a Roux-en-Y reconstruction.
The gross examination of the gastrectomy specimen
revealed a patelliform tumor measuring 3.2 cm in diameter
with depression and central ulcer. The cut section showedtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Lymphoepithelioma-like gastric carcinoma (LLC) on
biopsy specimens. It is difficult to recognize the LLC in the biopsy
specimens. In our case an outside diagnosis of poorly differentiated
adenocarcinoma of the stomach was made, the diagnosis was also
missed on the repeated biopsy in our institute too (HE Stain,
Magnification 2.5X, insertion: PAS stain Magnification 20X).
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wall (the muscularis propria). Five centimeter apart from
the tumor a 0.7 cm polypoid lesion was observed.
Histological, immunohistochemical and in situ
hybridization findings
Microscopically, the tumor was composed of sheets and
nests of round to polygonal cells with poorly defined
cell borders within a dense lymphocytic background.
Cytologically, the tumor cells were large and pleomorphic
with abundant eosinophilic cytoplasm, large vesicular
nuclei and prominent nucleoli (Figure 2a and 2b). No
vascular or lymphatic invasion was observed. No epi-
thelioid cell granulomas or Mott cells identified. None
of the 27 dissected lymph nodes showed metastasis.
The accompanying small polypoid lesion at the greatest
curvature was a hyperplastic polyp without adenomatous
changes.
Immunohistochemical staining for pan-cytokeratin
(CAM5.2 and AE1/AE3) was positive. The tumor was
negative for CK7, CK20, synaptophysin, CDX2 and CD45.
The in situ hybridization for EBV-encoded small
RNAs (EBER-1 and 2) showed an intensive nuclear
hybridization signal corresponding to the carcinoma
cells (Figure 2c), whereas the tumor was negative for
both LMP1 and EBNA2. No EBV hybridization signal
evident in the adjacent non-neoplastic gastric mucosa,
in the lymphocytes around the tumor cell or in the
dissected lymph nodes.P53 showed strong and diffuse positivity in the tumor
cells (Figure 2d). Regarding of the mismatch repair
proteins there was retention of expression of all four
of the proteins (MLH-1, PMS-2, MSH-2 and MSH-6)
(Figure 2e and 2f ).
Finally, EBV-associated LLC of the stomach was diag-
nosed and staged as (T2, N0, M0) according to the WHO
classification of tumors 2010.
The clinical course was complicated on the 5th postop-
erative day with insufficiency of the duodenal stump
which necessitated revision, and at nine months with
perforation of the left colonic flexure most probably of
ischemic genesis which was managed by laparotomy and
subtotal colectomy with side/side ileodescendostomy.
Fifteen months after the operation the patient remains
well with no evidence of recurrent disease.Discussion
LLCs are defined as tumors which possess histologic
similarity to nasopharyngeal carcinoma [8]. LLC of the
stomach is a rare type of gastric carcinoma that was
first described by Watanabe et al as gastric carcinoma
with a lymphoid stroma [1,2]. The stroma consists of
CD8- or CD4-positive T lymphocytes, and CD68-positive
macrophages, in a ratio of 2:1:1 and EBV infection is ob-
served only in a very limited number of these infiltrating
lymphocytes [6]. The reports in the literature with the syn-
onyms undifferentiated carcinoma with lymphoid stroma,
gastric Lymphoepithelioma-like carcinoma, or medullary
carcinoma all describe carcinomas with similar morph-
ology [9,10]. EBV-associated gastric LLC demonstrates a
male predominance, and like most gastric carcinomas,
occur in elderly people [11]. Although some reports
suggest that the carcinoma occurs in patients of rela-
tively younger age, meta analyses did not confirm this
observation [6].
LLC is also known as EBV-associated gastric carcinoma.
An etiologic association with EBV is based on the uniform
expression of EBV in all tumor cells while absent in
normal epithelium, dysplastic lesions [12] and lymphoid
cells. The mechanism by which EBV contributes to car-
cinogenesis in gastric mucosa is still unknown [13,14].
EBV-positive gastric LLC has been confirmed to be
composed of a monoclonal proliferation of a single EBV-
infected progenitor cell. This has strongly suggested
that EBV infects the gastric mucosa before neoplastic
transformation and is involved in the early stage of gastric
carcinogenesis [15-17].
The mechanism by which infection of the gastric epi-
thelial cells occurs is also poorly understood. The EBV
receptor, CD21, is not expressed on gastric mucosa, so
that the virus may enter the cells through an alternative
receptor or direct interaction of gastric epithelial cells
Figure 2 LLC in association with EBV. (a.) Loupe view of LLC. Note the well-circumscribed and expansive growth pattern with pushing borders
(HE Stain, Magnification 2.5X). (b.) Microscopic view of LLC (HE Stain, Magnification 40X). (c.) EBER in situ hybridization in LLC (EBV-ISH, Magnification
40X). (d.) P53 positivity in the tumor cells (Magnification 40X). (e.) Retention of expression of the mismatch repair protein MLH1 and MSH6
(f.) (Magnification 40X).
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cells [18] i.e. fusion-mechanism between EBV-infected
lymphocytes and epithelial cells. This has been also
supported by the fact that co-cultivation of virus pro-
ducing lymphocytes shows higher efficiency of infection
(up to 800-fold) than cell-free infection, therefore,
EBV-infected epithelial cells, probably in the neck zone
of fundic glands, are likely to initiate clonal growth to
develop EBV-associated gastric carcinoma. Atrophic
gastritis might induce the infiltration of EBV-carrying
lymphocytes to increase the chance of contact with
epithelial cells, or the inflammation may produce a
cytokine-rich milieu to support the clonal growth of
EBV-infected epithelial cells [6].
EBV is not integrated into the host DNA, but maintains
itself as an episomal circular form in the nuclei of
infected cells without the production of viral particles.
EBV replicates synchronously with the host chromo-
somes at cell division. The descendent carcinoma cells,
therefore, take over EBV-DNA of initially infected cells
even at the fully developed stage of carcinoma [6].The role of EBV in oncogenesis differs according to
the host cell type and the immune status of the host.
EBV-associated LLC belongs to the Latency I neoplasms,
in which latent gene products are restricted to EBV
nuclear antigen I (EBNA1), EBV-encoded small RNA
(EBER), latent membrane protein 2A (LMP2A), and
BamHI-A rightward transcripts (BARTs).
Representative viral proteins, EBNA2 and LMP1, are
not expressed in Latency I neoplasms [6]. The immuno-
histochemical (LMP1 and EBNA2 negativity) and in situ
hybridization findings (strong nuclear hybridization sig-
nal in tumor cells) in our case correspond to the Latency
I program.
The primary molecular abnormality in EBV associated
LLC of the stomach is global and non-random CpG
island methylation in the promoter region of many
cancer-related genes (such as LOX, HRASLS, FLNC,
HAND1, and THBD) [19].
Experimental studies have demonstrated that viral
LMP2A is responsible for the promotion of DNA methy-
lation. LMP2A up-regulates cellular DNMT1 through the
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tumor suppressor genes, such as PTEN, through promoter
methylation (immunohistochemistry confirmed the con-
current expression of pSTAT3 and DNMT1 in neoplastic
cells of LLC gastric carcinoma in vivo [20]).
In regards to the CpG-island methylation phenotype
(CIMP), gastric carcinoma has been classified into
three subgroups: CIMP none, intermediate, and high
(CIMP-N, -I, and -H) by the numbers of methylated
loci: 0, 1-3, and 4 or more, respectively [21]. Nearly all
cases of EBV associated LLC exhibited the CIMP-H
phenotype and concurrently showed frequent CpG-island
methylation in other cancer-related genes.
CpG-Methylation is not random in EBV-associated
LLC. It showed significantly higher frequencies of methy-
lation of cancer-related genes (p14ARF, p15, p16INK4A,
p73, TIMP3, E-cadherin, DAPK, and GSTP1) than EBV
negative/ CIMP-H LLC, except for the methylation of
hMLH1, and MGMT.
The methylation of hMLH1 promoter downregulates
its expression, causing a microsatellite instability (MSI)-
high phenotype, and is the main inactivation mechanism
of the hMLH1 gene responsible for MSI-H in gastric
carcinoma [22]. Several reports have reported that EBV
infection and MSI-H are mutually exclusive in gastric
carcinoma cases [5,23,24].
The prevalence of MSI-high in gastric carcinomas
ranges from 7- 39% whilst a geographic variability has
been found responsible for such a wide range [5].
Of the 3 cases that fulfilled the criteria for gastric
LLC in the study by Leung et al [25], 2 were EBV positive
but MSI negative, while the remaining case was EBV
negative with a high level of MSI.
Ojima et al [26] examined the immunoexpression of
p53 protein in EBV-positive and EBV-negative gastric
cancers. Overexpression of p53 protein was demonstrated
in only 8.4% of EBV-positive gastric cancers compared
with 34.4% of EBV-negative cases. A study by Leung et al
[27] found different results as all 18 EBV-associated gastric
cancers were p53 positive. In the case under discussion
the p53 protein was diffusely and strongly overexpressed
in the tumor cells, suggestive of P53 mutations.
The predominant locations of EBV-associated gastric
LLC are the cardia and middle portion of the stomach,
while MSI-high associated gastric carcinomas are more
common in the antrum [28]. The tumor in this case
locates in the distal third of the corpus at the greater
curvature.
LLC shows a lower rate of lymph node involvement,
especially during its early stage within the submucosa.
The incidence of multiple carcinomas also appears to
be higher in EBV-associated gastric carcinoma than in
EBV-negative carcinomas with EBV positivity reported
to be higher in synchronous multiple carcinomas thanin consecutive single carcinomas [6]. The tumor in our
case was single and the lymph node involvement was
not identified.
LLC of the stomach is known to have a favorable prog-
nosis despite the fact that they are poorly differentiated
carcinomas [12,29]. Watanabe et al. suggested that the
lymphocytic infiltration in LLC was a host defense
reaction against the cancer cells and that a more
extensive lymphocytic infiltration was indicative of
better prognosis [1]. It is unclear whether the survival
advantage is related to the lymphoid infiltrate, or
whether the EBV or MSI status itself serves as an
independent prognosticator [5]. However, by analyzing
a large series of patients, Beghelli et al concluded that
the MSI phenotype significantly correlates with survival
only in stage II neoplasms [30].
Conclusion
We describe a case of EBV-positive, microsatellite stable
LLC as a rare morphologic variant of gastric carcinoma,
which has special clinical and histological features that
distinguish it from other gastric adenocarcinomas. Although
EBV is considered one of the causative factors in the
development of this type of carcinomas, MSI is an-
other one.
The diagnosis of lymphoepithelioma-like gastric carcin-
omas should mainly rest on the characteristic morphology
and demonstration of EBV using different techniques. The
MSI status (as detected by immunohistochemistry or
PCR) is the other mainstay in the diagnosis with an im-
portant prognostic value.
LLC is difficult to recognize in the biopsy specimens
as the stromal lymphocyte infiltrate always thought
to be due to the ulceration. In spite, pathologists and
clinicians should acknowledge this subset of gastric
cancer because it generally has a better prognosis than
other forms of EBV-associated gastric carcinomas and
conventional gastric carcinomas.
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